We next applied TDS analysis of KRAS, PIK3CA, and PPP2R1A to not only the discovery cohort (n = 51; Fig. 1c, pink sequencing column) but also to the additional 19 adenomyosis patients (Fig. 1c, yellow sequencing column). This evidence concerns the gene KRAS and adenomyosis.